305 related articles for article (PubMed ID: 9856774)
1. Effect of matrix metalloproteinases activity on outflow in perfused human organ culture.
Bradley JM; Vranka J; Colvis CM; Conger DM; Alexander JP; Fisk AS; Samples JR; Acott TS
Invest Ophthalmol Vis Sci; 1998 Dec; 39(13):2649-58. PubMed ID: 9856774
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the levels of human trabecular matrix metalloproteinases and inhibitor by interleukin-1 and dexamethasone.
Samples JR; Alexander JP; Acott TS
Invest Ophthalmol Vis Sci; 1993 Nov; 34(12):3386-95. PubMed ID: 8225873
[TBL] [Abstract][Full Text] [Related]
3. Effects of mechanical stretching on trabecular matrix metalloproteinases.
Bradley JM; Kelley MJ; Zhu X; Anderssohn AM; Alexander JP; Acott TS
Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1505-13. PubMed ID: 11381054
[TBL] [Abstract][Full Text] [Related]
4. Expression of matrix metalloproteinases and inhibitor by human trabecular meshwork.
Alexander JP; Samples JR; Van Buskirk EM; Acott TS
Invest Ophthalmol Vis Sci; 1991 Jan; 32(1):172-80. PubMed ID: 1846130
[TBL] [Abstract][Full Text] [Related]
5. The effect of interleukin-1alpha on outflow facility in rat eyes.
Kee C; Seo K
J Glaucoma; 1997 Aug; 6(4):246-9. PubMed ID: 9264304
[TBL] [Abstract][Full Text] [Related]
6. Mediation of laser trabeculoplasty-induced matrix metalloproteinase expression by IL-1beta and TNFalpha.
Bradley JM; Anderssohn AM; Colvis CM; Parshley DE; Zhu XH; Ruddat MS; Samples JR; Acott TS
Invest Ophthalmol Vis Sci; 2000 Feb; 41(2):422-30. PubMed ID: 10670472
[TBL] [Abstract][Full Text] [Related]
7. Effects of cholesterol-lowering statins on the aqueous humor outflow pathway.
Song J; Deng PF; Stinnett SS; Epstein DL; Rao PV
Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2424-32. PubMed ID: 15980231
[TBL] [Abstract][Full Text] [Related]
8. CB2 cannabinoid receptors in trabecular meshwork cells mediate JWH015-induced enhancement of aqueous humor outflow facility.
Zhong L; Geng L; Njie Y; Feng W; Song ZH
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):1988-92. PubMed ID: 15914613
[TBL] [Abstract][Full Text] [Related]
9. The effect of cytochalasin D on outflow facility and the trabecular meshwork of the human eye in perfusion organ culture.
Johnson DH
Invest Ophthalmol Vis Sci; 1997 Dec; 38(13):2790-9. PubMed ID: 9418732
[TBL] [Abstract][Full Text] [Related]
10. Growth factor and cytokine modulation of trabecular meshwork matrix metalloproteinase and TIMP expression.
Alexander JP; Samples JR; Acott TS
Curr Eye Res; 1998 Mar; 17(3):276-85. PubMed ID: 9543636
[TBL] [Abstract][Full Text] [Related]
11. Laser trabeculoplasty induces stromelysin expression by trabecular juxtacanalicular cells.
Parshley DE; Bradley JM; Fisk A; Hadaegh A; Samples JR; Van Buskirk EM; Acott TS
Invest Ophthalmol Vis Sci; 1996 Apr; 37(5):795-804. PubMed ID: 8603864
[TBL] [Abstract][Full Text] [Related]
12. Expression of dominant negative Rho-binding domain of Rho-kinase in organ cultured human eye anterior segments increases aqueous humor outflow.
Rao PV; Deng P; Maddala R; Epstein DL; Li CY; Shimokawa H
Mol Vis; 2005 Apr; 11():288-97. PubMed ID: 15889013
[TBL] [Abstract][Full Text] [Related]
13. Gene transfer of dominant-negative RhoA increases outflow facility in perfused human anterior segment cultures.
Vittitow JL; Garg R; Rowlette LL; Epstein DL; O'Brien ET; Borrás T
Mol Vis; 2002 Mar; 8():32-44. PubMed ID: 11889464
[TBL] [Abstract][Full Text] [Related]
14. Perfusion of his-tagged eukaryotic myocilin increases outflow resistance in human anterior segments in the presence of aqueous humor.
Fautsch MP; Bahler CK; Vrabel AM; Howell KG; Loewen N; Teo WL; Poeschla EM; Johnson DH
Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):213-21. PubMed ID: 16384965
[TBL] [Abstract][Full Text] [Related]
15. Synergism of TNF and IL-1 in the induction of matrix metalloproteinase-3 in trabecular meshwork.
Kelley MJ; Rose AY; Song K; Chen Y; Bradley JM; Rookhuizen D; Acott TS
Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2634-43. PubMed ID: 17525194
[TBL] [Abstract][Full Text] [Related]
16. Modulation of aqueous humor outflow facility by the Rho kinase-specific inhibitor Y-27632.
Rao PV; Deng PF; Kumar J; Epstein DL
Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):1029-37. PubMed ID: 11274082
[TBL] [Abstract][Full Text] [Related]
17. Involvement of protein kinase C in TNFalpha regulation of trabecular matrix metalloproteinases and TIMPs.
Alexander JP; Acott TS
Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2831-8. PubMed ID: 11687525
[TBL] [Abstract][Full Text] [Related]
18. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
[TBL] [Abstract][Full Text] [Related]
19. The effect of IL-1alpha on the expression of matrix metalloproteinases, plasminogen activators, and their inhibitors in osteoblastic ROS 17/2.8 cells.
Fujisaki K; Tanabe N; Suzuki N; Mitsui N; Oka H; Ito K; Maeno M
Life Sci; 2006 Mar; 78(17):1975-82. PubMed ID: 16313928
[TBL] [Abstract][Full Text] [Related]
20. Effect of latanoprost on the expression of matrix metalloproteinases and their tissue inhibitors in human trabecular meshwork cells.
Oh DJ; Martin JL; Williams AJ; Russell P; Birk DE; Rhee DJ
Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3887-95. PubMed ID: 16936101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
